PharmaSGP Holding SE

PharmaSGP Holding SE is a German pharmaceutical company based in Gräfelfing, specializing in over-the-counter (OTC) healthcare products. Founded in 2012, the company develops, manufactures, and markets a range of non-prescription medications and wellness solutions. Their product portfolio addresses various health concerns, including pain management, sleep disorders, dermatological issues, and sexual health. The company primarily operates in Germany, which represents a significant portion of its sales, along with key markets in Italy and Austria. PharmaSGP has experienced notable revenue growth, increasing from €62.57 million in 2019 to €101 million in 2023. With a focus on non-chemical formulations and OTC accessibility, PharmaSGP aims to enhance its presence in the self-care market through product innovation and expansion across Europe. The company employs 89 staff members and offers a competitive annual dividend yield.

Pharmaceuticals Graefelfing, Germany ~91 employees ETRA: PSG.DE

Work at PharmaSGP Holding SE in HR or recruiting? Claim this page

Employees
91
Revenue / employee
$1.4M
Revenue ~$132M
Stock
PSG.DE
ETRA
H1B sponsor
NA

Peer reviews

Worked with someone at PharmaSGP Holding SE?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

PharmaSGP Holding SE FAQ

How many employees does PharmaSGP Holding SE have?

PharmaSGP Holding SE has about 91 employees (as of Nov 2025).

What is PharmaSGP Holding SE's revenue per employee?

PharmaSGP Holding SE makes about $1.45M in revenue per employee, based on $131.79M annual revenue and 91 employees.

Is PharmaSGP Holding SE a public company?

Yes. PharmaSGP Holding SE is publicly traded under the ticker PSG.DE on ETRA.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.